Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 238 (RN7SKP238) is a non-coding RNA pseudogene in the human genome, homologous to the functional 7SK small nuclear RNA gene (RN7SK) but lacking evidence for transcriptional activity or physiological function. The parent gene RN7SK is an RNA component of the 7SK small nuclear ribonucleoprotein (snRNP) complex, which regulates transcription elongation by RNA polymerase II and influences expression of small nuclear and small nucleolar RNAs, but the pseudogene derivative does not encode a functional product and is not implicated in therapeutic strategies or disease roles[2][1][3]. Pseudogenes like RN7SKP238 are often genomic remnants of functional genes, typically non-coding, and rarely serve as targets for drugs or biomarkers in clinical practice. The parent gene RN7SK is a long non-coding RNA critical for regulation of transcription and RNA processing, but therapeutic targeting or direct clinical relevance is tied to the parent gene, not its pseudogenes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 238 (RN7SKP238).